INTEC PHARMA LTD JERUSALEM's ticker is NTEC and the CUSIP is M53644148. A total of 20 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 443,008 | $1,936,000 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 46,917 | $205,000 | 0.03% |
| SABBY MANAGEMENT, LLC | 37,501 | $164,000 | 0.03% |
| MEITAV INVESTMENT HOUSE LTD | 120,991 | $529,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 11,396 | $50,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,089 | $65,000 | 0.00% |
| CREDIT SUISSE AG/ | 40,875 | $179,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 26,658 | $116,000 | 0.00% |
| MORGAN STANLEY | 1,129 | $5,000 | 0.00% |